Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
6 Months Ended |
---|---|
Dec. 31, 2017
USD ($)
| |
Beginning balance | $ 579,026 |
Acquisitions (Note 3) | 5,991 |
Currency translation | 4,084 |
Ending balance | 589,101 |
Biotechnology [Member] | |
Beginning balance | 254,930 |
Acquisitions (Note 3) | 5,991 |
Currency translation | 1,692 |
Ending balance | 262,613 |
Protein Platforms [Member] | |
Beginning balance | 220,826 |
Acquisitions (Note 3) | |
Currency translation | 2,392 |
Ending balance | 223,218 |
Diagnostics [Member] | |
Beginning balance | 103,270 |
Acquisitions (Note 3) | |
Currency translation | |
Ending balance | $ 103,270 |
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|